Bristol-Myers Squibb buy Truist Financial Co.
Start price
06.10.23
/
50%
€53.50
Target price
06.10.24
€79.27
Performance (%)
-8.08%
End price
07.10.24
€49.18
Summary
This prediction ended on 07.10.24 with a price of €49.18. With a performance of -8.08%, the BUY prediction by Truist_Financial_Co_ finished with a loss. Dividends of €2.20 are taken into consideration when calculating the performance. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Bristol-Myers Squibb | 2.341% | 2.341% | 18.170% |
| iShares Core DAX® | 3.593% | 3.931% | 15.378% |
| iShares Nasdaq 100 | 5.810% | 5.518% | 41.455% |
| iShares Nikkei 225® | 4.075% | 8.460% | 48.947% |
| iShares S&P 500 | 4.142% | 4.039% | 31.594% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Bristol-Myers Squibb diskutieren
Bristol-Myers Squibb (NYSE: BMY) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $84.00 price target on the stock.
Ratings data for BMY provided by MarketBeat
In the thread Trading Bristol-Myers Squibb
Die von Truist_Financial_Co_ gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Truist_Financial_Co_ for Bristol-Myers Squibb
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€55.56
08.01.25
08.01.25
€63.06
08.01.26
08.01.26
-13.17%
09.01.26
09.01.26
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€55.60
15.09.23
15.09.23
€78.67
15.09.24
15.09.24
-20.88%
16.09.24
16.09.24